CSIMarket


Regenxbio Inc   (RGNX)
Other Ticker:  
 

Regenxbio Inc

RGNX's Fundamental analysis








Looking into Regenxbio Inc growth rates, revenue grew by 9.06 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 1307

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -7.98 %

Regenxbio Inc net loss deacreased by in III. Quarter 2023 year on year, Regenxbio Inc net loss increased by -18.04 % in III. Quarter 2023 year on year,

More on RGNX's Growth


Regenxbio Inc
realized net loss in trailing twelve months.

Regenxbio Inc realized cash outflow of $ -1.49per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.79.


More on RGNX's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 331,247
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.12
 Tangible Book Value (Per Share $) 8.28

Regenxbio Inc
realized net loss in trailing twelve months.

Regenxbio Inc realized cash outflow of $ -1.49per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 7.01.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.79.

Regenxbio Inc Price to Book Ratio is at 1.92 lower than Indusry Avg. of 766.91. and higher than S&P 500 Avg. of 0.01

More on RGNX's Valuation

  Market Capitalization (Millions $) 696
  Shares Outstanding (Millions) 44
  Employees 300
  Revenues (TTM) (Millions $) 99
  Net Income (TTM) (Millions $) -261
  Cash Flow (TTM) (Millions $) -65
  Capital Exp. (TTM) (Millions $) -14
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 331,247
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 4.12
  Tangible Book Value (Per Share $) 8.28

  Market Capitalization (Millions $) 696
  Shares Outstanding (Millions) 44
  Employees 300
  Revenues (TTM) (Millions $) 99
  Net Income (TTM) (Millions $) -261
  Cash Flow (TTM) (Millions $) -65
  Capital Exp. (TTM) (Millions $) -14





  Ratio
   Capital Ratio (MRQ) 2.87
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.75
  Asset Turnover Ratio (TTM) 0.14
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com